Literature DB >> 12083448

The effect of HIV, behavioural change, and STD syndromic management on STD epidemiology in sub-Saharan Africa: simulations of Uganda.

E L Korenromp1, R Bakker, R Gray, M J Wawer, D Serwadda, J D F Habbema.   

Abstract

An assessment was made of how the HIV epidemic may have influenced sexually transmitted disease (STD) epidemiology in Uganda, and how HIV would affect the effectiveness of syndromic STD treatment programmes during different stages of the epidemic. The dynamic transmission model STDSIM was used to simulate the spread of HIV and four bacterial and one viral STD. Model parameters were quantified using demographic, behavioural, and epidemiological data from rural Rakai and other Ugandan populations. The findings suggest that severe HIV epidemics can markedly alter STD epidemiology, especially if accompanied by a behavioural response. Likely declines in bacterial causes of genital ulcers should be considered in defining policies on syndromic STD management in severe HIV epidemics.

Entities:  

Mesh:

Year:  2002        PMID: 12083448      PMCID: PMC1765831          DOI: 10.1136/sti.78.suppl_1.i55

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  13 in total

Review 1.  HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.

Authors:  Laith J Abu-Raddad; Joshua T Schiffer; Rhoda Ashley; Ghina Mumtaz; Ramzi A Alsallaq; Francisca Ayodeji Akala; Iris Semini; Gabriele Riedner; David Wilson
Journal:  Epidemics       Date:  2010-09-15       Impact factor: 4.396

2.  The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan.

Authors:  Nisso Kasymova; Benjamin Johns; Benusrat Sharipova
Journal:  Cost Eff Resour Alloc       Date:  2009-11-03

3.  The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model.

Authors:  Jan A C Hontelez; Nico Nagelkerke; Till Bärnighausen; Roel Bakker; Frank Tanser; Marie-Louise Newell; Mark N Lurie; Rob Baltussen; Sake J de Vlas
Journal:  Vaccine       Date:  2011-06-22       Impact factor: 3.641

4.  The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa.

Authors:  Jan A C Hontelez; Sake J de Vlas; Rob Baltussen; Marie-Louise Newell; Roel Bakker; Frank Tanser; Mark Lurie; Till Bärnighausen
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

5.  Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa.

Authors:  R G White; E E Freeman; K K Orroth; R Bakker; H A Weiss; N O'Farrell; A Buvé; R J Hayes; J R Glynn
Journal:  Sex Transm Infect       Date:  2008-10       Impact factor: 3.519

6.  Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.

Authors:  Esther E Freeman; Richard G White; Roel Bakker; Kate K Orroth; Helen A Weiss; Anne Buvé; Richard J Hayes; Judith R Glynn
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

7.  Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.

Authors:  Laith J Abu-Raddad; Amalia S Magaret; Connie Celum; Anna Wald; Ira M Longini; Steven G Self; Lawrence Corey
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

8.  Herpes simplex virus type 2 trends in relation to the HIV epidemic in northern Malawi.

Authors:  J R Glynn; A C Crampin; B M M Ngwira; R Ndhlovu; O Mwanyongo; P E M Fine
Journal:  Sex Transm Infect       Date:  2008-06-04       Impact factor: 3.519

9.  Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model.

Authors:  Eline L Korenromp; Benjamin Gobet; Erika Fazito; Joseph Lara; Lori Bollinger; John Stover
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

Review 10.  Individual-based simulation models of HIV transmission: reporting quality and recommendations.

Authors:  Nadia N Abuelezam; Kathryn Rough; George R Seage
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.